CFRA Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $102.73
Morgan Stanley Remains a Hold on Alcon (ALC)
Oppenheimer Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $110
J.P. Morgan Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $99.07
BofA Securities Maintains Alcon(ALC.US) With Hold Rating, Raises Target Price to $99.89
Alcon Analyst Ratings
Analysts Conflicted on These Healthcare Names: Alcon (ALC) and Telix Pharmaceuticals Ltd. (OtherTLPPF)
A Quick Look at Today's Ratings for Alcon(ALC.US), With a Forecast Between $98 to $120.85
Maintaining Buy Rating on Alcon Amid Strong Growth Catalysts and Solid Margin Trends
Alcon Price Target Raised to $98.00/Share From $96.00 by BTIG
Oppenheimer Sticks to Their Buy Rating for Alcon (ALC)
Buy Rating Justified for Alcon Amidst Strong Operational Performance and Promising Growth Outlook
Analysts Offer Insights on Healthcare Companies: Ansell (OtherANSLF), Alcon (ALC) and Regeneron (REGN)
Alcon's Steady Financial Performance and Growth Prospects Justify Buy Rating
Alcon Price Target Maintained With a $101.00/Share by Needham
Alcon Analyst Ratings
Citi Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $120.63
Alcon's Mixed Financial Performance Leads to Hold Rating Amidst Market Challenges
UBS Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $107.75
UBS Remains a Buy on Alcon (ALC)